Valuation: China Shineway Pharmaceutical Group Limited

Market Cap 4.67B 5.5B 701M 626M 578M 524M 980M 66.52B 996M 6.96B 2.75B 34.85B 2.63B 2.57B 110B P/E 2026 *
6.19x
P/E 2027 * 5.76x
Enterprise Value 4.67B 5.5B 701M 626M 578M 524M 980M 66.52B 996M 6.96B 2.75B 34.85B 2.63B 2.57B 110B EV / Sales 2026 *
1.99x
EV / Sales 2027 * 1.99x
Free-Float
33.69%
Yield 2026 *
-
Yield 2027 * -
1 day+0.76%
1 week-2.22%
Current month-12.77%
1 month-12.19%
3 months-11.60%
6 months-28.18%
Current year-15.41%
1 week 7.18
Extreme 7.185
7.6
1 month 7.12
Extreme 7.12
8.56
Current year 7.12
Extreme 7.12
10.47
1 year 7.12
Extreme 7.12
10.47
3 years 6.55
Extreme 6.55
10.76
5 years 4.63
Extreme 4.63
10.76
10 years 4.6
Extreme 4.6
18.54
Manager TitleAgeSince
Investor Relations Contact 60 -
Sales & Marketing 46 2019-11-30
Comptroller/Controller/Auditor 53 2011-01-31
Director TitleAgeSince
Chairman 70 2002-08-13
Director/Board Member 58 -
Director/Board Member 50 2020-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
10/31/22 Other

Director

280,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
+0.76%-2.22%-13.70%-0.21% 701M
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -0.52%+1.73%+31.85%+63.79% 400.5B
Weighted average by Cap. -0.26%+2.66%+40.98%+82.11%

Financials

2026 *2027 *
Net sales 2.34B 2.76B 351M 314M 290M 263M 492M 33.36B 500M 3.49B 1.38B 17.48B 1.32B 1.29B 55.1B 2.35B 2.76B 352M 314M 290M 263M 492M 33.4B 500M 3.49B 1.38B 17.5B 1.32B 1.29B 55.17B
Net income 755M 888M 113M 101M 93.38M 84.62M 158M 10.75B 161M 1.12B 445M 5.63B 425M 416M 17.75B 811M 953M 122M 109M 100M 90.9M 170M 11.54B 173M 1.21B 478M 6.05B 456M 447M 19.07B
Net Debt - -
Projected Income Statement - Annual - China Shineway Pharmaceutical Group Limited
Logo China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Ltd is an investment holding company primarily engaged in research and development, manufacturing and trading of Chinese pharmaceutical products. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The Company operates its business in mainland China and Hong Kong markets.
Employees
2,656
Date Price Change Volume
26-10-23 HK$7.275 +0.76% 575,000
26-10-22 HK$7.220 -1.90% 1,126,000
26-10-21 HK$7.360 -1.47% 831,240
26-10-20 HK$7.470 +0.40% 1,318,000
26-10-16 HK$7.440 -0.40% 618,000
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
BBB
MarketScreener Ratings - China Shineway Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
6.188CNY
Average target price
7.294CNY
Spread / Average Target
+17.88%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - China Shineway Pharmaceutical Group Limited
  1. Stock Market
  2. Stocks
  3. 2877 Stock